Richard Davidson, MD
Ophthalmology · Aurora, CONPI 1780774455
Payments from drug & device makers
Across 467 payments — averaging $677.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$76K
- Dompe US, Inc.$53K
- Carl Zeiss Meditec, Inc.$47K
- Novartis$20K
- AbbVie$19K
- Sun Pharmaceutical Industries Inc.$19K
- plus $82K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 83 | $75,522 |
| Dompe US, Inc. | 77 | $52,820 |
| Carl Zeiss Meditec, Inc. | 45 | $47,189 |
| Novartis | 26 | $20,485 |
| AbbVie(2 entities) | 28 | $19,356 |
| Sun Pharmaceutical Industries Inc. | 45 | $18,591 |
| Kala Pharmaceuticals, Inc. | 25 | $14,133 |
| Glaukos Corporation | 17 | $14,029 |
| Oyster Point Pharma, Inc. | 11 | $8,025 |
| Alcon Research LLC | 3 | $8,000 |
| Omeros Corporation | 2 | $6,636 |
| GSK | 1 | $5,850 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $5,605 |
| Shire North American Group Inc | 12 | $5,338 |
| Ocular Therapeutix, Inc. | 9 | $3,448 |
| Eyepoint US, Inc. | 4 | $1,917 |
| Sight Sciences, Inc. | 7 | $1,904 |
| Amgen | 1 | $1,800 |
| Bausch & Lomb Americas Inc. | 15 | $1,396 |
| Eyevance Pharmaceuticals LLC | 9 | $1,132 |
| Beaver-visitec International, Inc. | 3 | $991 |
| Carl Zeiss Meditec USA, Inc. | 12 | $796 |
| Tarsus Pharmaceuticals, Inc. | 8 | $612 |
| Ivantis, Inc | 1 | $137 |
| Lensar, Inc. | 1 | $124 |
| Genentech USA, Inc. | 1 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $118 |
| Johnson & Johnson Vision Care, Inc. | 1 | $96 |
| Rxsight Inc | 2 | $90 |
| Harrow Eye, LLC | 1 | $60 |
How this compares
$316,319 in reported general payments places this provider in the 90th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Aurora
- Darren GregoryAurora$5K
- Dhillon ZaverAurora$5K
- Kim BurrellAurora$5K
- Mark PackerBoulder$6.6M
- Ryan RichColorado Springs$2.1M
- Michael JansenDenver$1.8M
- Curtis HagedornDenver$1.5M
- Cristos IfantidesDenver$1.4M
- Jon DishlerGreenwood Village$1.1M
- James FoxGrand Junction$919K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.